An Interpretable Model-Based Prediction of Severity and Crucial Factors in Patients with COVID-19
Table 2
Chest CT features of the patients.
Mild group ()
Severe group ()
Stage
0.208
Early stage
44 (27.16%)
10 (27.78%)
Progress stage
105 (64.81%)
26 (72.22%)
Restoration stage
13 (8.02%)
0
Location
0.002
Subpleural
50 (30.86%)
2 (5.56%)
Scatter
54 (33.33%)
11 (30.56%)
Diffuse
58 (35.80%)
23 (63.89%)
Shape
<0.001
Nodular
11 (6.79%)
1 (2.78%)
Patchy
132 (81.48%)
17 (47.22%)
Large patchy
19 (11.73%)
18 (50.00%)
Number of lobes involved
<0.001
1
22 (13.58%)
0
2
22 (13.58%)
1 (2.78%)
3
20 (12.35%)
1 (2.78%)
4
34 (20.99%)
5 (13.89%)
5
64 (39.51%)
29 (80.56%)
Image manifestations
Pleural effusion
1 (0.62%)
4 (11.11%)
0.004
Fibrosis
64 (39.51%)
15 (41.67%)
0.811
Consolidation
85 (52.47%)
28 (77.78%)
0.006
Reticular shadow
95 (58.64%)
34 (94.44%)
<0.001
Crazy paving
9 (5.56%)
15 (41.67%)
<0.001
Air bronchogram
55 (33.95%)
26 (72.22%)
<0.001
Pleural thickening
62 (38.27%)
24 (66.67%)
0.002
Lymphadenovarix
10 (6.17%)
4 (11.11%)
0.493
GGO
162 (100.00%)
36 (100.00%)
—
Nodules
68 (41.98%)
19 (52.78%)
0.211
Quantitative features
CT from onset (days)
0.002
Total score
<0.001
UOR
<0.001
MOR
<0.001
IOR
<0.001
UOL
<0.001
IOL
<0.001
GGO: ground-glass opacity; UOR: upper lobe of right lung; MOR: middle lobe of right lung; IOR: inferior lobe of right lung; UOL: upper lobe of left lung; IOL: inferior lobe of left lung.
